• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Valeant Pharmaceuticals International, Inc. (VRX)

    -NYSE
    146.06 Up 3.06(2.14%) 4:01PM EST
    |After Hours : 146.06 0.00 (0.00%) 4:51PM EST
    Add to Portfolio
    Prev Close:143.00
    Open:143.91
    Bid:145.26 x 2000
    Ask:150.00 x 600
    1y Target Est:52.38
    Beta:0.72
    Next Earnings Date:N/A
    Day's Range:142.56 - 146.60
    52wk Range:106.00 - 153.10
    Volume:2,044,308
    Avg Vol (3m):2,639,260
    Market Cap:49.03B
    P/E (ttm):98.62
    EPS (ttm):1.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRXUp 2.14%49.03B
    TEVAUp 2.38%49.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.97
    Ex-Dividend Date:10-Nov-10

    Analysts

    Annual EPS Est (Dec-10) :N/A
    Quarterly EPS Est (Sep-10) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback